← brief for 2026-09-28 · People & money

MLN4924 suppresses kidney renal clear cell carcinoma progression through coordinated inhibition of Cullin1 neddylation and PSMB10-associated NF-κB inflammatory signaling

Article No results yet Peer reviewed

Key takeaways

This article describes a drug called MLN4924. It is being studied for its effect on a type of kidney cancer. The record does not include the study details or results, so there is no data to report yet.

Who did this work

Dequan Liu · Jing Su · Feng Chen · Lei Liu · Xiaochen Qi · Qifei Wang · Guangzhen Wu · 孙慧君 · Zhanmeng Zhu · Xiangyu Che

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-09-27
https://doi.org/10.1007/s00011-026-02363-x